[Effectiveness of oral hypoglycemic drugs in the metabolic control of patients with gestational diabetes].
Gestational Diabetes is characterized by different degrees of glucose intolerance that produce a series of fetal and perinatal alterations. During many years, in those cases of gestational diabetes that did not respond to nutritional interventions, the use of insulin was a proven treatment to achieve metabolic control and thus a better perinatal outcome. At present, some new oral hypoglycemic drugs, from the family of sulfonylureas and biguanides, have been shown to be safe, of low cost, and apparently effective in the metabolic control of this disease. We review the publications that propose the use of oral hypoglycemic drugs for the metabolic control of gestational diabetes that does not respond to nutritional measures.
Valdés R
Enrique
E
Unidad de Medicina Materno Fetal, Departamento de Obstetricia y Ginecología, Hospital Clínico Universidad de Chile, Santiago, Chile. evaldes@vtr.net
Soto-Chacón
Emiliano
E
Lahsen M
Rodolfo
R
Barrera H
Carlos
C
Candía P
Paula
P
D000284:Administration, Oral; D001645:Biguanides / Q000008:administration & dosage; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D016640:Diabetes, Gestational / Q000188:drug therapy* / Q000517:prevention & control; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage*; D011247:Pregnancy; D013453:Sulfonylurea Compounds / Q000008:administration & dosage; D016896:Treatment Outcome
D001645:Biguanides; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds